Kendall Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$735K Sell
3,930
-25
-0.6% -$4.6K 0.12% 147
2026
Q1
$746K Sell
3,955
-100
-2% -$21.1K 0.15% 137
2025
Q4
$806K Sell
4,055
-1,060
-21% -$214K 0.17% 128
2025
Q3
$1.04M Sell
5,115
-140
-3% -$24.8K 0.23% 105
2025
Q2
$925K Sell
5,255
-50
-0.9% -$7.53K 0.24% 103
2025
Q1
$714K Buy
5,305
+1,519
+40% +$200K 0.21% 123
2024
Q4
$478K Buy
+3,786
New +$563K 0.14% 149

Other funds holding THC

Kendall Capital Management's THC Position: Q2 2026 in Review

Kendall Capital Management reduced its Tenet Healthcare (THC) stake by 0.63% in Q2 2026, selling an estimated $4.6K and leaving 3,930 shares worth $735K. The position accounts for 0.12% of the portfolio, ranked #147.

Kendall Capital Management first reported a position in THC in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.04M in Q3 2025. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Kendall Capital Management held 3,930 shares of Tenet Healthcare worth $735K as of Q2 2026.
  • Kendall Capital Management sold 25 Tenet Healthcare shares in Q2 2026, an estimated $4.6K.
  • Tenet Healthcare made up 0.12% of Kendall Capital Management's portfolio in Q2 2026, its #147 holding.
  • Kendall Capital Management first reported a position in Tenet Healthcare in Q4 2024 and has held it in 7 quarters since.
  • Kendall Capital Management's Tenet Healthcare position peaked at $1.04M in Q3 2025.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Kendall Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.